BridgeBio Pharma Inc (BBIO) Reports Q3 2023 Financial Result

Revenue of $4.1 Million and Cash Position of $522 Million

Related Keywords

, Bridgebio Pharma Inc , European Medicines Agency , Bio Pharma Inc , Drug Administration , Key Program Updates , New Drug Application , Cash Equivalents , Equity Financing , Egulatory Meetings ,